Publications by authors named "T A Egorova"

Growing resistance to traditional antibiotics poses a global threat to public health. In this regard, modification of known antibiotics, but with limited applications due to side effects, is one of the extremely promising approaches at present. In this study, we proposed the synthesis of novel complex polymeric conjugates of the peptide antibiotic colistin (CT).

View Article and Find Full Text PDF
Article Synopsis
  • Solar particle events (SPEs) are bursts of high-energy particles from the sun that can significantly affect the Earth's environment, posing economic risks, especially when the geomagnetic field is weak.
  • Historic extreme SPEs can severely alter atmospheric chemistry, leading to ozone depletion and increased ground-level UV radiation, which can harm both the environment and human health.
  • Modeling suggests that under current geomagnetic conditions, extreme SPEs could elevate NO levels and reduce ozone, while a complete lack of geomagnetic protection could cause widespread ozone damage for years, increasing solar-induced DNA damage rates significantly.
View Article and Find Full Text PDF

The poly(A) tail plays an important role in maintaining mRNA stability and influences translation efficiency via binding with PABP. However, the impact of poly(A) tail length on mRNA translation remains incompletely understood. This study explores the effects of poly(A) tail length on human translation.

View Article and Find Full Text PDF

Polyelectrolyte complexes (PECs) based on polysaccharides, including hyaluronic acid (HA) and chitosan (CS), are promising delivery systems for antimicrobial agents, including oral administration of the peptide antibiotic colistin (CT). Modification of CS with different targeting ligands to improve intestinal permeability is a suitable way to improve the oral bioavailability of polyelectrolyte particles. This study describes the procedure for obtaining CT-containing PECs based on HA and CS modified with cyanocobalamin (vitamin B12).

View Article and Find Full Text PDF

RNA interference (RNAi)-based therapeutics hold the potential for dominant genetic disorders, enabling sequence-specific inhibition of pathogenic gene products. We aimed to direct RNAi for the selective suppression of the heterozygous c.607 G > A variant causing encephalopathy.

View Article and Find Full Text PDF